title: [Enoxaparin (clexane) in the prevention of thromboembolism after total hip replacement].
abstract: The efficiency and safety of use of enoxaparin (clexane Rhone-Poulenc Rorer) in antithrombotic prophylaxis after total hip replacement is presented. The subcutaneous dose of 40 mg daily proved to be highly efficient and of minor side-effects.
authors.affiliation: Kliniki Ortopedycznej AM w Warszawie.
authors.forename: I
authors.initials: I
authors.lastname: Babiak
authors.forename: T
authors.initials: T
authors.lastname: Jabłoński
authors.forename: J
authors.initials: J
authors.lastname: Serafin
mesh_terms: D000328:Adult; D000368:Aged; D017984:Enoxaparin / Q000627:therapeutic use*; D005260:Female; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
chemical_list: D017984:Enoxaparin
vernacular_title: Enoxaparyna (clexane) w zapobieganiu powikłaniom zakrzepowo-zatorwym po całkowitej endoprotezoplastyce stawu biodrowego.